FDA mulls "behind-the-counter" system for some drugs

The FDA said it will hold a hearing on Nov. 14 to discuss the possibility of allowing more drugs to be sold without a prescription through a "behind-the-counter" system. The system may allow pharmacists to determine whether a patient has met the requirements to receive certain medications and to guide patients on their proper use, according to a notice issued by the agency in today's Federal Register.

View Full Article in:

Chicago Tribune (tiered subscription model) · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX